Journals published by BioMed Central get new impact factors from ISI*
Impressive impact factors prove that BioMed Central's Open Access journals are high quality and widely read and cited. Journals published by BioMed Central have again received impact factors that compare well with equivalent subscription titles, it was announced today, with five titles in the top five of their specialty. The high impact factors for these journals affirm that they are respected by researchers, and are fast becoming the place for authors to submit important research findings.
Five journals published by BioMed Central received their first impact factors this year. BMC Bioinformatics, with an impact factor of 5.42, has reinforced its reputation as one of the top journals in its field. Launched in 2000, it is the second highest ranked bioinformatics journal, and already has an impact factor comparable to that of Bioinformatics (5.74), the most established journal in the field, which has been publishing for more than two decades and is supported by a major society.
BMC Genomics enters the Journal Citation Report with a respectable 3.25. This puts it in the top third of the genetics titles, and the top 20% of biotechnology journals. BMC Molecular Biology has an impact factor of 3.12, and BMC Musculoskeletal Disorders an impact factor of 1.00, putting it in the top half of the orthopaedics listing. BMC Genetics has an impact factor of 0.92.
Critical Care's impact factor jumped from 1.9 to 3.21, and the journal is now third in the critical care medicine field having leap-frogged the competitor title Intensive Care Medicine, the official journal of the major European society. Breast Cancer Research also increased it's impact factor from 2.93 to 2.98 and remains the second highest ranking breast cancer journal. Arthritis Research & Therapy maintains its rank of second in the rheumatology field with an impact factor of 4.55.
A number of other journal published by BioMed Central also saw their impact factors and rankings improve. BMC Infectious Diseases jumped from 1.25 to 2.07. BMC Cell Biology, with an impact factor of 2.62, is now in the top half of the cell biology listing. The impact factor for BMC Health Services Research almost doubled, from 0.68 to 1.23. BMC Cancer went up from 1.70 to 2.29 and BMC Public Health now has an impact factor of 1.55. With an impact factor of 4.03, Respiratory Research is the fifth most cited journal in the highly competitive respirology field.
The impact factors, which are calculated by ISI, look at citations in 2004 of articles published in the journals in the period 2002-2003. According to Dr Matthew Cockerill, Director of Operations at BioMed Central, "These latest impact factors show that BioMed Central's Open Access journals have joined the mainstream of science publishing, and can compete with traditional journals on their own terms. The impact factors also demonstrate one of the key benefits that Open Access offers authors: high visibility and, as a result, a high rate of citation."
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.
What is a cynic? A man who knows the price of everything and the value of nothing.
-- Oscar Wilde